Back to MW Marshall Wace, LLP
CRBP
7 quarters
Position history for MWMarshall Wace, LLP's holdings in Corbus Pharmaceuticals Holdings, Inc.
Yes. Marshall Wace holds 79,331 shares of CRBP (Corbus Pharmaceuticals Holdings), worth $744,125, as of its Q2 2026 13F filing. It reduced the position by 67,265 shares (-45.9%) from Q1 2026. Marshall Wace has held CRBP since Q2 2025, across 5 quarterly 13F filings.
Current Value
$744,125
Current Shares
79,331
Total Value Change
+$350,649
Total Shares Change
+60,258
Quarter-by-Quarter History
Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., State Street Corp., Adage Capital Partners GP, L.L.C., BlackRock, Inc.